Obesity and demographic ageing are two global megatrends that overlap in a particularly unfavorable way in the cardiovascular system. Both factors independently increase the risk of cardiovascular disease, but also interact at common biological levels: from cellular senescence and mitochondrial dysfunction to structural cardiac and vascular remodeling. The state-of-the-art review by Ruperez et al. in the European Heart Journal sheds light on how obesity accelerates biological cardiovascular ageing, which mechanistic intersections can be found and which metabolic therapy strategies – from calorie restriction to GLP-1 receptor agonists and SGLT2 inhibitors – can modulate these processes.
Autoren
- Tanja Schliebe
Publikation
- CARDIOVASC
Related Topics
You May Also Like
- Tinea capitis: Current Guidelines and Recommendations
What should be kept in mind when treating adult patients?
- Geriatric patients
Micronutrient Intake in Older Adults
- Crohn's disease: focus on long-term results
“Top-down” approach or classic step therapy?
- SwissDiab Study: New Analysis Published
How are diabetes complications associated with quality of life?
- Pre-acclimatization on Mount Everest
Exploring the physiological limits
- Viloxazine for ADHD
A non-stimulating option—but with limited evidence
- Preclinical study on phytotherapeutic agent
Active ingredient combination of peppermint and caraway oil modified fecal microbiota
- Casuistry